Investigation of the effect of recombinant human soluble thrombomodulin on the improvement of renal injury and mortality in septic patients with disseminated intravascular coagulatio
Not Applicable
Recruiting
- Conditions
- septic DIC
- Registration Number
- JPRN-UMIN000037245
- Lead Sponsor
- Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
the patients with chronic kidney disease on hemodialysis the patients who are under 18 years old
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the dependence of renal replacement therapy after ICU discharge
- Secondary Outcome Measures
Name Time Method the number of renal replacement therapy during ICU stay: the length of renal replacement therapy during ICU stay; the number of days free of continuous renal replacement therapy (CRRT free-days), serum creatinine level at ICU admission, ICU discharge, and hospital discharge, death at 28 days, 90 days, and 180 days